The RESILIENT-Extend trial, conducted in Brazil, shows that thrombectomy can be beneficial for patients with a large vessel occlusion stroke in an extended time window (8-24 hours) without the need for advanced and costly imaging. However, it was noted that there was no benefit with thrombectomy in older patients over 68 years of age, possibly due to frailty in this lower socioeconomic status population. The study indicates that population-specific factors such as socioeconomic status and frailty should be considered when evaluating the benefits of thrombectomy. There were conflicting results on the primary outcome, as thrombectomy increased the chances of a good outcome but also had a nonsignificant increased risk for a bad outcome.
Source link